<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The molecular and cellular mechanisms linking <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> and gastrointestinal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> are not known with certainty </plain></SENT>
<SENT sid="1" pm="."><plain>AIM: To investigate changes in potential causative factors during progression of <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">esophagus cancer</z:e> in a population living in high-risk area in Iran </plain></SENT>
<SENT sid="2" pm="."><plain>SUBJECTS: Formalin-fixed, paraffin-embedded esophageal specimens (n=87) from patients with <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>), Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (<z:chebi fb="49" ids="35181">ADC</z:chebi>) and <z:hpo ids='HP_0002860'>squamous cells carcinoma</z:hpo> (<z:mp ids='MP_0004207'>SCC</z:mp>) were collected based on their pathological diagnosis </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Immunohistochemical (IHC) technique was used to study tissue accumulation of P53, P21, cyclooxygenase-2 (COX-2), <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase-P (GST-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Pi</z:e>) and nitrotyrosine (NT) in patients and controls </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: P53 expression was not detected in esophageal tissues from <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> samples, whereas it was found positive in Barrett's, <z:chebi fb="49" ids="35181">ADC</z:chebi>, and <z:mp ids='MP_0004207'>SCC</z:mp> samples </plain></SENT>
<SENT sid="5" pm="."><plain>P21 positive sample was relatively higher in <z:chebi fb="49" ids="35181">ADC</z:chebi> patients as compared to that in <z:mp ids='MP_0004207'>SCC</z:mp> (<z:chebi fb="49" ids="35181">ADC</z:chebi>: 52.6%; <z:mp ids='MP_0004207'>SCC</z:mp>: 25%) </plain></SENT>
<SENT sid="6" pm="."><plain>GST-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Pi</z:e> expression was equally accumulated in <z:hpo ids='HP_0000001'>all</z:hpo> the samples </plain></SENT>
<SENT sid="7" pm="."><plain>NT was predominantly expressed in <z:chebi fb="49" ids="35181">ADC</z:chebi> (72.7%) </plain></SENT>
<SENT sid="8" pm="."><plain>COX-2 expression was significantly higher in Barrett's (60.0%) and <z:chebi fb="49" ids="35181">ADC</z:chebi> (66.6%) as compared to that in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, <z:mp ids='MP_0004207'>SCC</z:mp> and <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>These data were further confirmed by detecting the scores of immunostainings in <z:hpo ids='HP_0000001'>all</z:hpo> the positive samples </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: The pathological changes in <z:chebi fb="49" ids="35181">ADC</z:chebi> and <z:mp ids='MP_0004207'>SCC</z:mp> samples which were associated with increasing frequency of NT and COX-2 provides further evidence for involvement of these inflammatory factors in progression of <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">esophagus cancer</z:e> </plain></SENT>
</text></document>